Effect of smoking history
on 30-day morbidity and
mortality following
bariatric surgery
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METHODS
• MBSAQIP (2015-2018) data was retrospectively reviewed
• Adults (≥18 years of age) who had primary laparoscopic sleeve
gastrectomy (LSG) or Roux-en-Y gastric bypass (LRYGB) were included
• Patients were excluded if they had:
• Any prior obesity surgery; revision or conversion procedure
• Open or converted to open surgery
• Were lost to follow-up within 30 days after index procedure
• Records with missing data
• Patients meeting criteria were stratified into two groups:
• Smoke history (SH)
• No smoke history (NSH)
• Perioperative factors and 30-day postoperative outcomes were assessed

Patient Operative Characteristics
Age, Mean (SD)
BMI, Mean (SD)

INTRODUCTION
• Smoking and postoperative complications are well document across
surgical specialties. Preoperative smoking cessation is frequently
recommended by surgeons. In this study, we assessed to what degree
documented smoking history increased a patient’s risk of postoperative
complications

OBJECTIVE
• Our objective was to investigate how the documented smoking history,
within 1 year of bariatric surgery, affects on the morbidity and mortality
outcomes
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41.8 (10.8)
46.4 (7.8)
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Hispanic, n (%)
Female, n (%)
Male, n (%)
Cardiac surgery or other intervention,
n (%)
Chronic obstructive pulmonary
disease
Dialysis, n (%)
Diabetes mellitus, n (%)

62319 (13)
381445 (79.5)
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Functional status: partially/totally
dependent, n (%)
Gastroesophageal reflux disease, n
(%)
Hyperlipidemia, n (%)
Hypertension, n (%)
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14403 (32.3)

114137 (23.8)
233306 (48.6)
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Pulmonary embolism, n (%)
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Obstructive sleep apnea, n (%)
Steroid use, n (%)
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Operative length, mean (SD)
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Reoperation, p <0.001
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Table 1: Demographic and Operative Factors

Black or African American, n (%)
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Results

Unplanned Intubation, p =0.021
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Figure 1: The rates for postoperative complications in SH group was significantly higher than in in the NSH group.

Conclusions
• Patient with Smoking history have a higher likelihood of readmission and
reoperation within 30-days of primary bariatric surgery.
• SH patients were more likely to have unplanned intubation, and
unplanned ICU admission.
• The current study supports preoperative smoking cessation in patients
prior to primary bariatric surgery.
• Further study is warranted to compare short-term cessation vs. long-term
cessation preoperatively, which was not assessed in our study.

